|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.12 USD | -0.16% |
|
+6.22% | +8.39% |
| 06-29 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
Chart calendar Zai Lab Limited
Upcoming events on Zai Lab Limited
No events available
Past events on Zai Lab Limited
| 17/06/2026 | Annual General Meeting | 13:00 |
| 17/06/2026 | Présentation aux Actionnaires / Analystes | 13:00 |
| 07/05/2026 | Earnings presentation | 13:00 |
| 07/05/2026 | Earnings release - Q1 2026 | |
| 20/04/2026 | Information meeting | 13:30 |
| 27/03/2026 | Board of Directors Meeting | |
| 27/03/2026 | Earnings release - Annual 2025 | |
| 26/02/2026 | Earnings release - Q4 2025 | |
| 26/02/2026 | Earnings presentation | 13:00 |
| 06/11/2025 | Earnings presentation | 13:00 |
| 06/11/2025 | Earnings release - Q3 2025 | |
| 24/10/2025 | Information meeting | 16:00 |
| 07/08/2025 | Earnings presentation | 13:00 |
| 07/08/2025 | Earnings release - Q2 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 267 269 -0.77% | 399 393 1.45% | 460 467 -1.56% | 449 | 596 | 756 |
|
EBITDA Million USD | Released Forecast Spread | -358 -342 -4.68% | -270 -304 11.03% | -214 -184 -16.51% | -243 | -160 | -66,6 |
|
EBIT Million USD | Released Forecast Spread | -367 -351 -4.32% | -282 -306 7.8% | -229 -200 -14.8% | -259 | -174 | -85,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -335 -354 5.6% | -257 -282 8.76% | -178 -166 -7.3% | -233 | -143 | -127 |
|
Net income Million USD | Released Forecast Spread | -335 -348 3.74% | -257 -280 8.02% | -176 -175 -0.56% | -241 | -156 | -126 |
|
EPS USD | Released Forecast Spread | -3,46 -3,47 0.18% | -2,60 -2,71 4.05% | -1,60 -1,68 4.69% | -2,21 | -1,86 | -1,35 |
| Announcement Date | 27/02/24 | 27/02/25 | 26/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 102 102 0.02% | 109 110 -0.98% | 106 116 -8.09% | 110 125 -12.03% | 116 144 -19.23% | 128 123 4.02% | 99,6 108 -8.14% | 104 | 111 | 119 | 132 | 143 | 152 | 165 |
|
EBITDA Million USD | Released Forecast Spread | -65,0 -75,4 13.78% | -64,9 -64,5 -0.54% | -51,2 -28,4 -79.94% | -44,9 -39,3 -14.34% | -65,5 -45,2 -45.02% | -65,4 -54,5 -20.03% | -63,1 | -59,9 | -61,4 | |||||
|
EBIT Million USD | Released Forecast Spread | -67,9 -83,1 18.31% | -67,9 -72,9 6.87% | -56,3 -59,8 5.84% | -54,9 -47,9 -14.69% | -48,8 -39,2 -24.42% | -69,4 -43,4 -60.08% | -69,4 -60,0 -15.63% | -77,0 | -61,7 | -62,4 | -59,1 | -54,3 | -50,5 | -43,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -41,7 -74,8 44.31% | -81,7 -64,0 -27.73% | -48,4 -54,4 10.88% | -40,7 -46,7 12.79% | -36,0 -24,8 -45.01% | -53,3 -27,6 -93.42% | -49,6 -61,6 19.49% | -78,1 | -55,7 | -54,0 | -54,5 | -49,7 | -45,9 | -38,6 |
|
Net income Million USD | Released Forecast Spread | -41,7 -77,0 45.9% | -81,7 -65,1 -25.47% | -48,4 -54,8 11.66% | -40,7 -45,7 10.78% | -36,0 -26,8 -34.02% | -50,4 -35,8 -40.78% | -51,0 -62,3 18.13% | -74,8 | -57,6 | -55,3 | -54,5 | -49,7 | -45,9 | -38,6 |
|
EPS USD | Released Forecast Spread | -0,42 -0,78 46.49% | -0,80 -0,61 -31.27% | -0,45 -0,57 20.35% | -0,37 -0,42 11.9% | -0,33 -0,24 -37.5% | -0,46 -0,35 -31.67% | -0,46 -0,56 18.53% | -0,67 | -0,52 | -0,50 | -0,49 | -0,45 | -0,41 | -0,35 |
| Announcement Date | 12/11/24 | 27/02/25 | 08/05/25 | 07/08/25 | 06/11/25 | 26/02/26 | 07/05/26 | - | - | - | - | - | - | - |
| 08/07/2026 |  | Extraordinary General Meeting | 14:00 |
| 08/07/2026 | | Présentation aux Actionnaires / Analystes | 14:00 |
| 08/07/2026 | | Extraordinary General Meeting | 07:30 |
| 08/07/2026 | | Ex-dividend date for special dividend - 1 EUR | 05:00 |
| 09/07/2026 | | Extraordinary General Meeting | 07:00 |
| 13/07/2026 | | Ex-dividend date - 0.15 CNY | 05:00 |
| 16/07/2026 | | Earnings release - Q2 2026 | 07:00 |
| 16/07/2026 | | Earnings presentation | 13:00 |
| 16/07/2026 | | Earnings presentation | 09:00 |
| 16/07/2026 | | Earnings release - Q2 2026 |
Past sector events for Zai Lab Limited
| 02/07/2026 | | Extraordinary General Meeting | 07:00 |
| 30/06/2026 | | Ex-dividend date - 0.06673 EUR | 05:00 |
| 30/06/2026 | | Annual General Meeting | |
| 30/06/2026 | | Annual General Meeting | 02:30 |
| 29/06/2026 | | Annual General Meeting | 02:00 |
| 29/06/2026 | | Extraordinary General Meeting | 08:00 |
| 29/06/2026 | | Extraordinary General Meeting | 08:00 |
| 26/06/2026 | | Extraordinary General Meeting | 07:00 |
| 26/06/2026 | | Annual General Meeting | 07:30 |
| 26/06/2026 | | Annual General Meeting | 06:30 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ZLAB Stock
- Calendar Zai Lab Limited
Select your edition
All financial news and data tailored to specific country editions
